As in the case of insulin and IR, the expression of the ligand (IGF1) and its receptor (IGF1R) within the same tumor could provide proof of an autocrine-paracrine signaling loop of RCC cells stimulation (Schips et al. 2004). The gene discussed is IGF1R; the disease is neoplasm.